Opportunity
Simpler Grants.gov #PAR-25-274
NIH Grant for Feasibility Clinical Trials of Mind and Body Interventions
Buyer
National Institutes of Health
Posted
November 21, 2024
Respond By
November 17, 2026
Identifier
PAR-25-274
NAICS
541715
This opportunity from the National Institutes of Health (NIH), via the National Center for Complementary and Integrative Health (NCCIH), seeks applications for feasibility clinical trials of mind and body interventions. - Government Buyer: - National Institutes of Health (NIH) - National Center for Complementary and Integrative Health (NCCIH) - No OEMs or commercial vendors are specified, as this is a research grant rather than a product or service procurement. - Products/Services Requested: - Feasibility clinical trials focused on complementary and integrative health approaches involving mind and body interventions - Activities include intervention tailoring, recruitment feasibility, protocol refinement, and assessment of acceptability and adherence - Unique/Notable Requirements: - Applicants must demonstrate the scientific necessity of the proposed feasibility study for planning future full-scale clinical trials - Research must address high-priority topics identified by NCCIH - Eligible applicants include government entities, educational institutions, nonprofits, and businesses - No specific part numbers, quantities, or commercial products are requested, as this is a grant for research activities
Description
This funding opportunity supports feasibility clinical trials of complementary and integrative health approaches involving mind and body interventions for conditions identified as high-priority by NCCIH. The trials aim to provide new scientific information necessary for planning subsequent full-scale clinical efficacy, effectiveness, pragmatic, or dissemination and implementation studies. Applicants must demonstrate that the proposed research is essential for designing the future clinical trial, addressing gaps such as intervention feasibility, acceptability, tailoring, recruitment, and protocol refinement. The ultimate goal is to conduct a full-scale clinical trial with significant public health impact.